Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's ...

and founding investor Medicxi – will go in part towards clinical testing of Vicebio's lead vaccine VXB-241 for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), which is in ...

A COVID-19 vaccine developed using the technology cleared a phase 1 proof-of-concept study in Australia, but Vicebio is focusing first on RSV, with clinical trials of VXB-211 scheduled to in the ...

Vaccines developer Vicebio unveiled $100 million in financing as it begins a Phase 1 test of VXB-241, a bivalent vaccine designed to address both respiratory syncytial virus (RSV) )and human ...

Does the new RSV vaccine have any side effects? In adults, the most frequently reported side effects have been soreness at the injection site, muscle pain, fatigue, headache and joint pain. In the ...

But with respiratory syncytial virus, or RSV, how old you are can affect how sick you get. “Respiratory syncytial virus does present differently in folks of different ages,” says Kisha Davis ...

More information: Angela R Branche, Real-world effectiveness studies of the benefit of RSV vaccines, The Lancet (2024).DOI: 10.1016/S0140-6736(24)02150-0 Amanda B Payne et al, Respiratory ...

In addition to flu and COVID-19 shots, respiratory syncytial virus (RSV) vaccines are available for the most vulnerable. Here’s what you need to know. While most people who contract RSV can ...

The just-opened immunization program is targeting respiratory syncytial virus (RSV), a seasonal disease that triggers mild symptoms in most but can be a particular threat to infants in their firs ...

The Centers for Disease Control and Prevention (CDC) recently warned that respiratory syncytial virus (RSV) and mycoplasma pneumonia, or “walking pneumonia,” are on the rise among very young ...